S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Deep Track Capital/Q4 2024

Deep Track Capital

Period: Q4 2024 Β· Filed: 2025-02-14
View on SEC EDGAR β†—
AUM
$2.68B
Total portfolio value
Positions
63
Reported securities
Top Holding
DVAX
8.5% $227.2M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2025-02-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
DVAXDYNAVAX TECHNOLOGIES CORP$227.2M8.47%β€”β€”
8.5%
GHGUARDANT HEALTH INC$196.1M7.31%$30.55$167.98+449.9%
7.3%
ITCIINTRA-CELLULAR THERAPIES INC$167.0M6.23%β€”β€”
6.2%
IMVTIMMUNOVANT INC$148.6M5.54%$24.77$38.79+56.6%
5.5%
APLSAPELLIS PHARMACEUTICALS INC$136.4M5.09%$31.91β€”
5.1%
SWTXSPRINGWORKS THERAPEUTICS INC$125.0M4.66%β€”β€”
4.7%
CYTKCYTOKINETICS INC$117.6M4.39%$47.04$86.49+83.9%
4.4%
OCULOCULAR THERAPEUTIX INC$109.6M4.09%$8.54$9.64+12.9%
4.1%
VRDNVIRIDIAN THERAPEUTICS INC$86.7M3.23%$19.17$19.40+1.2%
3.2%
PLRXPLIANT THERAPEUTICS INC$78.7M2.93%$13.17$1.17-91.1%
2.9%
GPCRSTRUCTURE THERAPEUTICS INC$75.9M2.83%$27.12$53.45+97.1%
2.8%
IONSIONIS PHARMACEUTICALS INC$67.6M2.52%$34.96$81.80+134.0%
2.5%
NRIXNURIX THERAPEUTICS INC$56.5M2.11%$18.84$23.97+27.2%
2.1%
MBXMBX BIOSCIENCES INC$55.6M2.08%$18.43$57.80+213.6%
2.1%
ETNB89BIO INC$50.7M1.89%β€”β€”
1.9%
HRMYHARMONY BIOSCIENCES HLDGS IN$49.9M1.86%$34.41$37.26+8.3%
1.9%
DYNDYNE THERAPEUTICS INC$47.1M1.76%$23.56$23.07-2.1%
1.8%
SEPNSEPTERNA INC$43.8M1.63%$22.90$34.00+48.5%
1.6%
NMRANEUMORA THERAPEUTICS INC.$42.4M1.58%$10.60$1.67-84.3%
1.6%
GMABGENMAB A/S$41.7M1.56%$20.87$28.51+36.6%
1.6%
AKROAKERO THERAPEUTICS INC$41.5M1.55%β€”β€”
1.6%
VRNAVERONA PHARMA PLC$39.5M1.47%β€”β€”
1.5%
CLDXCELLDEX THERAPEUTICS INC NEW$38.9M1.45%$25.27$38.37+51.8%
1.4%
PTGXPROTAGONIST THERAPEUTICS INC$38.6M1.44%$38.60$131.62+241.0%
1.4%
ANIPANI PHARMACEUTICALS INC$35.9M1.34%$55.28$86.03+55.6%
1.3%
BCAXBICARA THERAPEUTICS INC$34.8M1.30%$17.42$29.00+66.5%
1.3%
AUTLAUTOLUS THERAPEUTICS PLC$33.4M1.25%$2.35$1.58-32.8%
1.3%
KRROKORRO BIO INC$33.3M1.24%$38.07$14.00-63.2%
1.2%
TERNTERNS PHARMACEUTICALS INC$30.9M1.15%$5.54β€”
1.1%
ENGNENGENE HOLDINGS INC$30.3M1.13%$6.65$1.78-73.2%
1.1%

Quarter-on-Quarter Activity

Q4 2024 vs. Q3 2024

New Positions (8)

TickerIssuerNotionalSince Filing
HRMYHARMONY BIOSCIENCES HLDGS IN$49.9M+8.3%
SEPNSEPTERNA INC$43.8M+48.5%
GMABGENMAB A/S$41.7M+36.6%
CLDXCELLDEX THERAPEUTICS INC NEW$38.9M+51.8%
PTGXPROTAGONIST THERAPEUTICS INC$38.6M+241.0%
RAREULTRAGENYX PHARMACEUTICAL IN$27.5M
BBIOBRIDGEBIO PHARMA INC$22.5M
LKFTGALAPAGOS NV$21.5M

Exited Positions (8)

TickerIssuerNotional
ARGXARGENX SE$197.9M
NTLAINTELLIA THERAPEUTICS INC$101.7M
ALKSALKERMES PLC$98.0M
AXSMAXSOME THERAPEUTICS INC$77.0M
APGEAPOGEE THERAPEUTICS INC$58.7M
TGTXTG THERAPEUTICS INC$40.4M
KURAKURA ONCOLOGY INC$38.4M
KYMRKYMERA THERAPEUTICS INC$28.4M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
NMRACALLNEUMORA THERAPEUTICS INC.$40.0M+2116.1%-84.3%
NMRACALLNEUMORA THERAPEUTICS INC.$34.9M+604.9%-84.3%
NMRACALLNEUMORA THERAPEUTICS INC.$10.2M+559.2%-84.3%
CYTKCYTOKINETICS INC$84.3M+296.9%+83.9%
BCAXBICARA THERAPEUTICS INC$14.5M+151.0%+66.5%
ETNB89BIO INC$30.2M+134.2%
GPCRSTRUCTURE THERAPEUTICS INC$22.4M+129.4%+97.1%
AKROAKERO THERAPEUTICS INC$21.7M+116.0%

Trimmed (8)

TickerIssuerNotionalShares Ξ”
NKTRNEKTAR THERAPEUTICS$-18.9M-87.6%
FDMT4D MOLECULAR THERAPEUTICS IN$-40.9M-85.1%
SYRESPYRE THERAPEUTICS INC$-24.3M-78.1%
VRNAVERONA PHARMA PLC$-52.0M-73.3%
BCYCBICYCLE THERAPEUTICS PLC$-62.4M-64.0%
MNMDMIND MEDICINE MINDMED INC$-20.6M-60.1%
CLYMCLIMB BIO INC$-9.2M-52.0%
GERNGERON CORP$-20.2M-47.0%
← Back to Hedge Funds